Digital Diagnostics, formerly IDx, is a pioneering AI diagnostics company founded with a mission to transform the quality, accessibility, equity, and affordability of healthcare worldwide through the application of technology in the medical diagnosis and treatment process. The company has developed a patented biomarker-based approach to build an autonomous AI platform that makes clinical decisions without human intervention, removing the diagnostic burden of common diseases from specialists.

Digital Diagnostics Inc.

Digital Diagnostics is a pioneering AI diagnostics company on a mission to transform the quality, accessibility and affordability of healthcare. Founded and led by Dr. Michael Abramoff, an ophthalmologist, neuroscientist and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build autonomous algorithms that make clinical decisions without human intervention. Digital Diagnostics and its flagship product IDx-DR, an autonomous AI system FDA-authorized to diagnose diabetic retinopathy and diabetic macular edema, has proven that intelligent diagnostic platforms can be used safely, efficiently and equitably to improve patient outcomes. As it expands into other diagnostic capabilities, Digital Diagnostics has paved the way for automated diagnosis to become a new standard of care that will contribute significantly to democratizing healthcare.   

Alpha Edison

Optum Ventures

Heritage Provider Network

Edward-Elmhurst Health

Kinderhook Industries

Gundersen Health System

University of Iowa

OSF Ventures

Kohlberg Kravis Roberts

Cedar Pine

Digital Diagnostics 

Given the widespread impact of diabetes on people worldwide, research efforts to learn more about the condition are ongoing across the globe. For instance, according to an article published by Medical News Today, scientists at the RIKEN Center for Integrative Medical Sciences in Japan recently discovered an order of bacteria that may help protect against type 2 diabetes and obesity by improving insulin resistance. 

Learn more here: https://hubs.la/Q02f8L-_0

#DigitalDiagnostics #LumineticsCore #GlobalHealth #Diabetes


If you're a team player who's willing to jump into any problem, you might be perfect for our Senior Cloud Engineer position. 

Find out more and apply here: https://hubs.la/Q02f69xC0

#DigitalDiagnostics #LumineticsCore #Hiring #Engineering


As part of our commitment to bring high quality AI diagnosis to the point-of-care, we’ve partnered with OSF HealthCare. 

“The positive impact our partnership with OSF HealthCare is having in the lives of patients is exactly in line with our mission. Offering LumineticsCore™ [formerly IDx-DR] to patients in a setting where they are already comfortable, coupled with the high-quality care offered at OSF, furthers our organizations’ collective goal of improving patient outcomes,” said Digital Diagnostics’ Senior Vice President of Commercial, Sean Murnane.

Learn more about how OSF Healthcare is increasing access to innovative patient care with our AI diagnostics system here: https://hubs.la/Q02d_wNC0

#DigitalDiagnostics #LumineticsCore #AItheRightWay #Healthcare


Regular comprehensive eye exams are one of the best ways to help prevent vision loss or blindness in people with diabetes. This video from Prevent Blindness emphasizes the importance of these appointments by highlighting how diabetes can affect both vision and mental health.

Watch the video here: https://hubs.la/Q02dWLS50

#DigitalDiagnositcs #LumineticsCore #Diabetes #Healthcare 


Metric
Company Name	Digital Diagnostics Inc.
Symbol
MSH ID	COM:DIGITALDIAGNOSTICS
Market	PRIVATE
Sector	Artificial Intelligence (AI)
Industry	Healthcare Technology
Country	US
Stage
Employee Count	113
Website	digitaldiagnostics.com
LinkedIn	digital-diagnostics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:DIGITALDIAGNOSTICS

Digital Diagnostics Inc.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue